An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore

Authors:

Abstract
Prostate cancer is the fifth most common cancer in Asian men, and with its rising incidence, is emerging as a health priority in Asia.1 Across Asian countries, age-standardised incidence rates (ASIRs) of prostate cancer range from 0.9 to 56.1 per 100,000 population, with the second highest ASIR reported in Singapore (30.7 per 100,000 population) in

This publication has 91 references indexed in Scilit: